Company page
Xcell Therapeutics, Inc.
Xcell Therapeutics, Inc. is a public company traded under the ticker 373110 on the Korean market. The company has a market capitalization of approximately 14.9 million USD. Xcell Therapeutics focuses on developing innovative therapeutic solutions.
- Ticker
- 373110:KRX
- Asset type
- Stock
- Market cap
- $14.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW